CROI 2022 的 CCO 独立会议报道*:新 HIV 数据的临床影响 *

2022年2月13-16日; 虚拟的
通过实时网络研讨会、便捷内容摘要和可下载的幻灯片了解有关 HIV 治疗策略、预防和最佳实践的最新数据,并从 CROI 2022 关键研究的伴随评论和播客中获得全球视角。

Share

Program Content

Activities

ClinicalThought:病毒学失败后的多替拉韦
我对病毒学失败患者使用多替拉韦的看法:来自 CROI 2022 的数据
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Activities

幻灯片:CROI 2022
影响我在 CROI 2022 之后的实践的关键 HIV 研究
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 21, 2022

Expires: March 20, 2023

Provided by

ProCE Banner

Supporters

由 Gilead Sciences, Inc. 提供的教育补助金 支持。 Janssen Therapeutics,Janssen Products, LP 的事业部 Merck & Co., Inc. ViiV Healthcare

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck & Co., Inc.

ViiV Healthcare

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.